Morgan, C. L., Owens, D. R., Aubonnet, P. ., Carr, E. S., Jenkins-Jones, S. ., Poole, C. D., & Currie, C. J. (2013). Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2013-004025
C. Morgan
First name
C.
Middle name
L.
Last name
Morgan
Holden, S. E., Jenkins-Jones, S. ., Poole, C. D., Morgan, C. L., Coghill, D. ., & Currie, C. J. (2013). The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health. http://doi.org/10.1186/1753-2000-7-34
Currie, C. J., Poole, C. D., Evans, M. ., Peters, J. R., & Morgan, C. L. (2013). Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3042
Holden, S. H., Barnett, A. H., Peters, J. R., Jenkins-Jones, S. ., Poole, C. D., Morgan, C. L., & Currie, C. J. (2013). The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. http://doi.org/10.1111/dom.12123
Bannister, C. A., Poole, C. D., Jenkins-Jones, S. ., Morgan, C. L., Elwyn, G. ., Spasic, I. ., & Currie, C. J. (2014). External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations. Diabetes Care. http://doi.org/10.2337/dc13-1159
Morgan, C. L., Puelles, J. ., Poole, C. D., & Currie, C. J. (2014). The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: a retrospective cohort study. J Diabetes Complications. http://doi.org/10.1016/j.jdiacomp.2014.01.007
Morgan, C. L., Mukherjee, J. ., Jenkins-Jones, S. ., Holden, S. E., & Currie, C. J. (2014). Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12302
Morgan, C. L., Mukherjee, J. ., Jenkins-Jones, S. ., Holden, S. E., & Currie, C. J. (2014). Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality. Diabetes Obes Metab. http://doi.org/10.1111/dom.12306
Bannister, C. A., Holden, S. E., Jenkins-Jones, S. ., Morgan, C. L., Halcox, J. P., Schernthaner, G. ., … Currie, C. J. (2014). Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab. http://doi.org/10.1111/dom.12354
Currie, C. J., Berni, E. ., Jenkins-Jones, S. ., Poole, C. D., Ouwens, M. ., Driessen, S. ., … Morgan, C. L. (2014). Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis. Bmj. http://doi.org/10.1136/bmj.g5493